Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma: an Observational Retrospective Multicenter Study

NCT07111104 is registered in ClinicalTrials.gov with Hopitaux Prives de Metz, Groupe UNEOS as lead sponsor.

NCT NCT07111104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07111104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung Carcinoma: an Observational Retrospective Multicenter Study
Lead sponsor
Hopitaux Prives de Metz, Groupe UNEOS
Phase
Observational
Overall status
Completed
Start date
October 14, 2024
Completion date
April 28, 2025
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer metastatic